These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18277395)

  • 1. Proceedings of the 18th Annual Meeting of the Japanese Society for Kidney Bone Disease, February 24, 2007, Tokyo, Japan.
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S1-66. PubMed ID: 18277395
    [No Abstract]   [Full Text] [Related]  

  • 2. 18th annual meeting of the Japanese Society for Kidney Bone Diseases. Preface.
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S1-2. PubMed ID: 17976079
    [No Abstract]   [Full Text] [Related]  

  • 3. 19th Annual Meeting of the Japanese Society for Kidney Bone Disease.
    Akizawa T
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S1. PubMed ID: 19032519
    [No Abstract]   [Full Text] [Related]  

  • 4. [The course of osteodystrophy in patients with chronic kidney failure on hemodialysis].
    Zemchenko AIu; Shostka GD
    Urol Nefrol (Mosk); 1993; (6):51-4. PubMed ID: 8160326
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone disease in patients with chronic renal failure and during long-term hemodialysis].
    Flury W
    Ther Umsch; 1972 Sep; 29(9):554-9. PubMed ID: 4628712
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathophysiology and treatment of renal osteodystrophy].
    Ionova D
    Vutr Boles; 1985; 24(6):23-9. PubMed ID: 3913143
    [No Abstract]   [Full Text] [Related]  

  • 7. Can a dietitian help prevent renal bone disease in the hemodialysis patient?
    Harum P
    Nephrol News Issues; 1990 Sep; 4(9):35, 37, 42. PubMed ID: 2402318
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surgical treatment of secondary hyperparathyroidism].
    D'Alonzo U
    Minerva Med; 1985 Mar; 76(9-10):389-91. PubMed ID: 3982695
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evolution of surgical methods in the treatment of renal osteodystrophy. Personal cases and remote results].
    Borrelli D; Cicchi P; Burci P; Perigli G; Bandini S; Solfanelli E
    Minerva Med; 1985 Mar; 76(9-10):429-39. PubMed ID: 3982701
    [No Abstract]   [Full Text] [Related]  

  • 10. Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients: rationale and study design.
    Fukuhara S; Akizawa T; Fukagawa M; Onishi Y; Yamaguchi T; Hasegawa T; Kurokawa K
    Ther Apher Dial; 2011 Apr; 15(2):169-75. PubMed ID: 21426510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal osteopathy in long-term dialysis therapy--comparison of the alkaline phosphatase isoenzyme in bone with histologic findings].
    Hájková B; Erben J; Kubes L; Rouchal J
    Vnitr Lek; 1985 May; 31(5):447-50. PubMed ID: 4024490
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of renal osteodystrophy.
    Sakhaee K
    Semin Nephrol; 1992 Mar; 12(2):101-8. PubMed ID: 1561490
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients].
    Goto S; Fukagawa M
    Clin Calcium; 2007 Dec; 17(12):1830-4. PubMed ID: 18057657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients.
    Pizzarelli F; Zoccali C; Ciccarelli C; Maggiore Q; Bonucci E; Ballanti P
    Nephron; 1982; 32(1):93-4. PubMed ID: 7177287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe jaw enlargement associated with uremic hyperparathyroidism.
    Tarrass F; Benjelloun M; Bensaha T
    Hemodial Int; 2008 Jul; 12(3):316-8. PubMed ID: 18638085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can renal bone disease be prevented?
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
    Ogata H; Koiwa F; Shishido K; Kinugasa E
    Ther Apher Dial; 2005 Feb; 9(1):11-5. PubMed ID: 15828900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for parathyroidectomy in patients with chronic renal failure.
    Finch T; Jacobs JK
    Am Surg; 1974 Jan; 40(1):40-4. PubMed ID: 4808621
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic indications obtained from short- and medium-term biohumoral changes after parathyroidectomy].
    Sforzini S; Viganò MR; Rosa M; Redaelli B
    Minerva Med; 1985 Mar; 76(9-10):393-6. PubMed ID: 3982696
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.